TreeWAS – Variant ID: rs78935958

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.019	0.981	0.000
K22.7 Barrett's oesophagus	0.000	0.981	0.019
D47.2 Monoclonal gammopathy	0.018	0.982	0.000
D47.1 Chronic myeloproliferative disease	0.018	0.982	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.017	0.983	0.000
N95.0 Postmenopausal bleeding	0.000	0.984	0.016
D47.4 Osteomyelofibrosis	0.015	0.985	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.015	0.985	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.014	0.986	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.014	0.986	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.014	0.986	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.014	0.986	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.014	0.986	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.014	0.986	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.014	0.986	0.000
D43.2 Brain, unspecified	0.013	0.987	0.000
I20.0 Unstable angina	0.000	0.987	0.013
D38.1 Trachea, bronchus and lung	0.012	0.987	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.012	0.988	0.000
D37.2 Small intestine	0.012	0.988	0.000
D37.3 Appendix	0.012	0.988	0.000
N95 Menopausal and other perimenopausal disorders	0.000	0.989	0.011
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.011	0.989	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.011	0.989	0.000
D37.0 Lip, oral cavity and pharynx	0.011	0.989	0.000
D46 Myelodysplastic syndromes	0.011	0.989	0.000
D37.5 Rectum	0.011	0.989	0.000
N95.2 Postmenopausal atrophic vaginitis	0.000	0.989	0.011
D37.1 Stomach	0.011	0.989	0.000
D45 Polycythaemia vera	0.011	0.989	0.000
D43.0 Brain, supratentorial	0.010	0.989	0.000
D37.9 Digestive organ, unspecified	0.010	0.990	0.000
D37.6 Liver, gallbladder and bile ducts	0.010	0.990	0.000
D43.9 Central nervous system, unspecified	0.010	0.990	0.000
D43.7 Other parts of central nervous system	0.010	0.990	0.000
D43.4 Spinal cord	0.010	0.990	0.000
D43.3 Cranial nerves	0.010	0.990	0.000
D43.1 Brain, infratentorial	0.010	0.990	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.010	0.990	0.000
D37.4 Colon	0.010	0.990	0.000
K92.1 Melaena	0.010	0.990	0.000
D38.6 Respiratory organ, unspecified	0.010	0.990	0.000
D38.5 Other respiratory organs	0.010	0.990	0.000
D38.4 Thymus	0.010	0.990	0.000
D38.3 Mediastinum	0.010	0.990	0.000
D38.2 Pleura	0.010	0.990	0.000
D38.0 Larynx	0.010	0.990	0.000
D37.7 Other digestive organs	0.010	0.990	0.000
D40.0 Prostate	0.010	0.990	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.009	0.991	0.000
N95.1 Menopausal and female climacteric states	0.000	0.991	0.009
D40.9 Male genital organ, unspecified	0.009	0.991	0.000
D40.7 Other male genital organs	0.009	0.991	0.000
D40.1 Testis	0.009	0.991	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.009	0.991	0.000
N95.3 States associated with artificial menopause	0.000	0.991	0.009
N95.9 Menopausal and perimenopausal disorder, unspecified	0.000	0.992	0.008
D42.9 Meninges, unspecified	0.008	0.992	0.000
D42.1 Spinal meninges	0.008	0.992	0.000
D42.0 Cerebral meninges	0.008	0.992	0.000
D44.9 Endocrine gland, unspecified	0.008	0.992	0.000
D44.8 Pluriglandular involvement	0.008	0.992	0.000
D44.7 Aortic body and other paraganglia	0.008	0.992	0.000
D44.6 Carotid body	0.008	0.992	0.000
D44.5 Pineal gland	0.008	0.992	0.000
D44.4 Craniopharyngeal duct	0.008	0.992	0.000
D44.3 Pituitary gland	0.008	0.992	0.000
D44.2 Parathyroid gland	0.008	0.992	0.000
D44.1 Adrenal gland	0.008	0.992	0.000
D44.0 Thyroid gland	0.008	0.992	0.000
D46.7 Other myelodysplastic syndromes	0.008	0.992	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.008	0.992	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.008	0.992	0.000
D46.4 Refractory anaemia, unspecified	0.008	0.992	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.008	0.992	0.000
D46.2 Refractory anaemia with excess of blasts	0.008	0.992	0.000
D46.1 Refractory anaemia with sideroblasts	0.008	0.992	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.008	0.992	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.008	0.992	0.000
C50.9 Breast, unspecified	0.000	0.992	0.008
C71.1 Frontal lobe	0.008	0.992	0.000
D48.1 Connective and other soft tissue	0.008	0.992	0.000
D39.9 Female genital organ, unspecified	0.007	0.992	0.000
D39.7 Other female genital organs	0.007	0.992	0.000
D39.2 Placenta	0.007	0.992	0.000
D39.0 Uterus	0.007	0.992	0.000
N39.4 Other specified urinary incontinence	0.008	0.992	0.000
D41.0 Kidney	0.007	0.993	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.007	0.993	0.000
D48.4 Peritoneum	0.007	0.993	0.000
D48.3 Retroperitoneum	0.007	0.993	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.007	0.993	0.000
D41.9 Urinary organ, unspecified	0.006	0.993	0.000
D41.7 Other urinary organs	0.006	0.993	0.000
D41.3 Urethra	0.006	0.993	0.000
D41.2 Ureter	0.006	0.993	0.000
D41.1 Renal pelvis	0.006	0.993	0.000
D48.5 Skin	0.006	0.993	0.000
K22 Other diseases of oesophagus	0.000	0.993	0.007
D39.1 Ovary	0.006	0.994	0.000
C71.9 Brain, unspecified	0.006	0.994	0.000
D48.6 Breast	0.006	0.994	0.000
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.994	0.006
C71 Malignant neoplasm of brain	0.006	0.994	0.000
D48.7 Other specified sites	0.006	0.994	0.000
K22.5 Diverticulum of oesophagus, acquired	0.000	0.994	0.006
D48.0 Bone and articular cartilage	0.006	0.994	0.000
K22.9 Disease of oesophagus, unspecified	0.000	0.994	0.006
C50.8 Overlapping lesion of breast	0.000	0.995	0.005
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.000	0.995	0.005
L03.0 Cellulitis of finger and toe	0.000	0.995	0.005
C50.2 Upper-inner quadrant of breast	0.000	0.995	0.005
K22.3 Perforation of oesophagus	0.000	0.995	0.005
G43.9 Migraine, unspecified	0.005	0.995	0.000
C50 Malignant neoplasm of breast	0.000	0.995	0.005
C71.8 Overlapping lesion of brain	0.005	0.995	0.000
C71.7 Brain stem	0.005	0.995	0.000
C71.6 Cerebellum	0.005	0.995	0.000
C71.5 Cerebral ventricle	0.005	0.995	0.000
C71.4 Occipital lobe	0.005	0.995	0.000
C71.0 Cerebrum, except lobes and ventricles	0.005	0.995	0.000
Z95.4 Presence of other heart-valve replacement	0.000	0.995	0.005
I20 Angina pectoris	0.000	0.995	0.005
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.995	0.005
K22.8 Other specified diseases of oesophagus	0.000	0.995	0.005
K22.4 Dyskinesia of oesophagus	0.000	0.995	0.005
L03.8 Cellulitis of other sites	0.000	0.995	0.004
C71.3 Parietal lobe	0.004	0.996	0.000
C71.2 Temporal lobe	0.004	0.996	0.000
L03 Cellulitis	0.000	0.996	0.004
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.996	0.004
K22.0 Achalasia of cardia	0.000	0.996	0.004
K22.1 Ulcer of oesophagus	0.000	0.996	0.004
K92 Other diseases of digestive system	0.004	0.996	0.000
I20.8 Other forms of angina pectoris	0.000	0.996	0.004
L03.9 Cellulitis, unspecified	0.000	0.996	0.004
N93.8 Other specified abnormal uterine and vaginal bleeding	0.004	0.996	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.996	0.004
M54.56 Low back pain (Lumbar region)	0.000	0.996	0.004
C50.6 Axillary tail of breast	0.000	0.996	0.004
L03.2 Cellulitis of face	0.000	0.996	0.004
C50.0 Nipple and areola	0.000	0.996	0.003
K92.2 Gastro-intestinal haemorrhage, unspecified	0.004	0.996	0.000
L03.3 Cellulitis of trunk	0.000	0.996	0.003
O30.0 Twin pregnancy	0.003	0.996	0.000
K92.8 Other specified diseases of digestive system	0.003	0.997	0.000
Z95.3 Presence of xenogenic heart valve	0.000	0.997	0.003
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
J34.2 Deviated nasal septum	0.000	0.997	0.003
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
I20.1 Angina pectoris with documented spasm	0.000	0.997	0.003
K92.9 Disease of digestive system, unspecified	0.003	0.997	0.000
C50.3 Lower-inner quadrant of breast	0.000	0.997	0.003
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.000	0.997	0.003
T91.9 Sequelae of unspecified injury of neck and trunk	0.003	0.997	0.000
T91 Sequelae of injuries of neck and trunk	0.003	0.997	0.000
D41.4 Bladder	0.002	0.997	0.001
T91.8 Sequelae of other specified injuries of neck and trunk	0.003	0.997	0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.000	0.997	0.003
T91.2 Sequelae of other fracture of thorax and pelvis	0.003	0.997	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.997	0.003
N21.0 Calculus in bladder	0.003	0.997	0.000
C50.1 Central portion of breast	0.000	0.997	0.003
A49.0 Staphylococcal infection, unspecified	0.000	0.997	0.003
F31 Bipolar affective disorder	0.003	0.997	0.000
R93 Abnormal findings on diagnostic imaging of other body structures	0.000	0.997	0.003
F31.6 Bipolar affective disorder, current episode mixed	0.003	0.997	0.000
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.003	0.997	0.000
M20.1 Hallux valgus (acquired)	0.003	0.997	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.000	0.997	0.003
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.003	0.997	0.000
T91.3 Sequelae of injury of spinal cord	0.003	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.002	0.997	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.997	0.000
C70 Malignant neoplasm of meninges	0.002	0.997	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.997	0.003
D22.3 Melanocytic naevi of other and unspecified parts of face	0.003	0.997	0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.000	0.997	0.002
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.997	0.002
L05 Pilonidal cyst	0.000	0.997	0.002
Z95.2 Presence of prosthetic heart valve	0.000	0.998	0.002
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.998	0.000
C50-C50 Malignant neoplasm of breast	0.000	0.998	0.002
I20.9 Angina pectoris, unspecified	0.000	0.998	0.002
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
F31.9 Bipolar affective disorder, unspecified	0.002	0.998	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.002	0.998	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.002	0.998	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.002	0.998	0.000
C50.5 Lower-outer quadrant of breast	0.000	0.998	0.002
K22.2 Oesophageal obstruction	0.000	0.998	0.002
L05.0 Pilonidal cyst with abscess	0.000	0.998	0.002
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.998	0.002
G43 Migraine	0.002	0.998	0.000
Z34.0 Supervision of normal first pregnancy	0.002	0.998	0.000
F31.8 Other bipolar affective disorders	0.002	0.998	0.000
F31.7 Bipolar affective disorder, currently in remission	0.002	0.998	0.000
R93.6 Abnormal findings on diagnostic imaging of limbs	0.000	0.998	0.002
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.000	0.998	0.002
K08.8 Other specified disorders of teeth and supporting structures	0.000	0.998	0.002
Z92.1 Personal history of long-term (current) use of anticoagulants	0.000	0.998	0.002
K50.0 Crohn's disease of small intestine	0.002	0.998	0.000
C69.3 Choroid	0.002	0.998	0.000
C69.9 Eye, unspecified	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.6 Orbit	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
C69.0 Conjunctiva	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
C70.9 Meninges, unspecified	0.002	0.998	0.000
C70.1 Spinal meninges	0.002	0.998	0.000
C70.0 Cerebral meninges	0.002	0.998	0.000
C72.9 Central nervous system, unspecified	0.002	0.998	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.002	0.998	0.000
C72.5 Other and unspecified cranial nerves	0.002	0.998	0.000
C72.4 Acoustic nerve	0.002	0.998	0.000
C72.3 Optic nerve	0.002	0.998	0.000
C72.2 Olfactory nerve	0.002	0.998	0.000
C72.1 Cauda equina	0.002	0.998	0.000
C72.0 Spinal cord	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
C45.9 Mesothelioma, unspecified	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Z37.2 Twins, both liveborn	0.002	0.998	0.000
K08.3 Retained dental root	0.000	0.998	0.002
Z95.1 Presence of aortocoronary bypass graft	0.000	0.998	0.002
O30 Multiple gestation	0.002	0.998	0.000
D05.1 Intraductal carcinoma in situ	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
C45 Mesothelioma	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.000	0.998	0.002
G43.8 Other migraine	0.002	0.998	0.000
G43.3 Complicated migraine	0.002	0.998	0.000
G43.2 Status migrainosus	0.002	0.998	0.000
G43.0 Migraine without aura [common migraine]	0.002	0.998	0.000
Z95.0 Presence of cardiac pacemaker	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.998	0.002
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
G43.1 Migraine with aura [classical migraine]	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
H02.8 Other specified disorders of eyelid	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
C50.4 Upper-outer quadrant of breast	0.000	0.998	0.002
S62.60 Fracture of other finger (closed)	0.000	0.998	0.002
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.002	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
A49 Bacterial infection of unspecified site	0.000	0.998	0.002
D27 Benign neoplasm of ovary	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
L89.1 Stage II decubitus ulcer	0.000	0.998	0.002
O30.9 Multiple gestation, unspecified	0.002	0.998	0.000
O30.8 Other multiple gestation	0.002	0.998	0.000
O30.2 Quadruplet pregnancy	0.002	0.998	0.000
O30.1 Triplet pregnancy	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.002	0.998	0.000
C45.1 Mesothelioma of peritoneum	0.002	0.998	0.000
L04 Acute lymphadenitis	0.000	0.998	0.002
L01 Impetigo	0.000	0.998	0.002
L00 Staphylococcal scalded skin syndrome	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.998	0.002
H02.6 Xanthelasma of eyelid	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
Y41.5 Antiviral drugs	0.001	0.998	0.000
Y41.4 Anthelminthics	0.001	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
Y41.1 Antimycobacterial drugs	0.001	0.998	0.000
Y41.0 Sulphonamides	0.001	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Z34.8 Supervision of other normal pregnancy	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
A49.9 Bacterial infection, unspecified	0.000	0.998	0.002
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.002	0.998	0.000
I12.0 Hypertensive renal disease with renal failure	0.000	0.998	0.002
N92.6 Irregular menstruation, unspecified	0.000	0.998	0.002
Y47.1 Benzodiazepines	0.001	0.998	0.000
Z34 Supervision of normal pregnancy	0.002	0.998	0.000
C48.0 Retroperitoneum	0.001	0.998	0.000
J18.1 Lobar pneumonia, unspecified	0.000	0.998	0.002
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
K08 Other disorders of teeth and supporting structures	0.000	0.998	0.002
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
F05.9 Delirium, unspecified	0.000	0.998	0.002
Y45.2 Propionic acid derivatives	0.001	0.998	0.000
Y46.8 Antispasticity drugs	0.001	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.998	0.000
Y46.5 Valproic acid	0.001	0.998	0.000
Y46.4 Iminostilbenes	0.001	0.998	0.000
Y46.3 Deoxybarbiturates	0.001	0.998	0.000
Y46.1 Oxazolidinediones	0.001	0.998	0.000
Y46.0 Succinimides	0.001	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.998	0.000
D05 Carcinoma in situ of breast	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.001	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.001	0.998	0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.000	0.998	0.001
M54.3 Sciatica	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
A49.3 Mycoplasma infection, unspecified	0.000	0.998	0.001
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.998	0.001
G50.0 Trigeminal neuralgia	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.001	0.998	0.000
I63.8 Other cerebral infarction	0.001	0.998	0.000
K50.8 Other Crohn's disease	0.001	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.998	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.001	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.000	0.999	0.001
L01.1 Impetiginisation of other dermatoses	0.000	0.999	0.001
L01.0 Impetigo [any organism] [any site]	0.000	0.999	0.001
L04.9 Acute lymphadenitis, unspecified	0.000	0.999	0.001
L04.8 Acute lymphadenitis of other sites	0.000	0.999	0.001
L04.3 Acute lymphadenitis of lower limb	0.000	0.999	0.001
L04.2 Acute lymphadenitis of upper limb	0.000	0.999	0.001
L04.1 Acute lymphadenitis of trunk	0.000	0.999	0.001
L04.0 Acute lymphadenitis of face, head and neck	0.000	0.999	0.001
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.001	0.999	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.001	0.999	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.001	0.999	0.000
C85.0 Lymphosarcoma	0.001	0.999	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.001	0.999	0.000
W18.3 Sports and athletics area	0.001	0.999	0.000
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.5 Aminoglycosides	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y40.3 Macrolides	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
N21 Calculus of lower urinary tract	0.001	0.999	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.001	0.999	0.000
C48.2 Peritoneum, unspecified	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000
Y58.4 Tetanus vaccine	0.001	0.999	0.000
Y58.3 Plague vaccine	0.001	0.999	0.000
Y58.2 Cholera vaccine	0.001	0.999	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.999	0.000
Y58.0 BCG vaccine	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
Y59.2 Protozoal vaccines	0.001	0.999	0.000
Y59.1 Rickettsial vaccines	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
M54.37 Sciatica (Lumbosacral region)	0.000	0.999	0.001
A49.8 Other bacterial infections of unspecified site	0.000	0.999	0.001
C85.1 B-cell lymphoma, unspecified	0.001	0.999	0.000
G25.0 Essential tremor	0.001	0.999	0.000
K08.0 Exfoliation of teeth due to systemic causes	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Z29.8 Other specified prophylactic measures	0.001	0.999	0.000
D05.7 Other carcinoma in situ of breast	0.001	0.999	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.001	0.999	0.000
D05.0 Lobular carcinoma in situ	0.001	0.999	0.000
G93.2 Benign intracranial hypertension	0.001	0.999	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.999	0.001
Y49.5 Other antipsychotics and neuroleptics	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M54.35 Sciatica (Thoracolumbar region)	0.000	0.999	0.001
M54.34 Sciatica-Thoracic	0.000	0.999	0.001
M54.33 Sciatica-Cervicothoracic	0.000	0.999	0.001
M54.32 Sciatica-Cervical	0.000	0.999	0.001
M54.31 Sciatica-Occipit-atl-axl	0.000	0.999	0.001
M54.30 Sciatica (Multiple sites in spine)	0.000	0.999	0.001
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.999	0.000
T39.4 Antirheumatics, not elsewhere classified	0.001	0.999	0.000
T39.2 Pyrazolone derivatives	0.001	0.999	0.000
Y40.8 Other systemic antibiotics	0.001	0.999	0.000
Y44.2 Anticoagulants	0.001	0.999	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.999	0.001
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.001	0.999	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.001	0.999	0.000
Y40.0 Penicillins	0.001	0.999	0.000
Y57.8 Other drugs and medicaments	0.001	0.999	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.999	0.000
Y57.6 Other diagnostic agents	0.001	0.999	0.000
Y57.5 X-ray contrast media	0.001	0.999	0.000
Y57.4 Pharmaceutical excipients	0.001	0.999	0.000
Y57.3 Alcohol deterrents	0.001	0.999	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
Y57.1 Lipotropic drugs	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations